ProQR Therapeutics N.V. Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
ProQR Therapeutics N.V. (PRQR) reported Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used of EUR 17.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed · last filed 2026-03-12
| Period end | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month |
|---|---|
| 2025-12-31 | 17.00K EUR 20-F · filed 2026-03-12 |
| 2024-12-31 | 7.00K EUR 20-F · filed 2026-03-12 |
| 2023-12-31 | 28.00K EUR 20-F · filed 2026-03-12 |
| 2022-12-31 | 94.00K EUR 20-F · filed 2025-03-13 |
| 2021-12-31 | 70.00K EUR 20-F · filed 2024-03-13 |
| 2020-12-31 | 141.00K EUR 20-F · filed 2022-04-29 |
| 2019-12-31 | 189.00K EUR 20-F · filed 2021-03-24 |